$BMY.d
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Stocks
$9.62
$64.15
▲+11.41%from 30d ago
1
$9.62
Tokenized Stock Metrics
Metric
Show % of Total
Market Cap by Network
as of 08/12/2026
Key Facts
Name
Bristol-Myers Squibb Co.
Ticker
BMY.d
CUSIP
—
ISIN
—
Platform
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
—
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$10
△
NAV
$64.15
▲
Price
—
Token Supply
0.15
△
Circulating Supply
0.15
△
7D APY
—
30D APY
—
Holders
1
△
Trailing 30D Active Addresses
1
△
Monthly Transfer Count
1
△
Monthly Transfer Volume
$10
△
Tokens
Primary Market
Eligible Investors
—
Base Assets
—
Subscription Time
—
Min. Investment
—
Subscription Fees
0%
Subscription Description
—
Redemption Time
—
Minimum Redemption Amount
—
Redemption Fees
0%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
Dinari
Issuer LEI
—
Issuer CIK
Domicile
United States of America
Regulatory Framework
U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0%
Subscription Fees
0%
RWA.xyzAll Rights Reserved